Ischaemic Stroke Keeps Time: A Critical Review of Circadian Biology from Thrombus Formation to Translational Failure

Ischaemic stroke does not occur at random hours. Onset clusters in the morning, and several physiological correlates of that pattern are well described: an endogenous circadian peak in circulating plasminogen activator inhibitor-1, platelets that aggregate more readily in the hours after rising, and the morning surge in blood pressure. What remains unsettled is whether the hour of onset also influences how quickly brain tissue is lost and how well it responds to treatment. This critical narrative review draws together molecular, experimental and clinical evidence and organises it as a Three-Clock Model: a trigger clock that sets when vessels occlude, a tissue clock that governs the pace of infarct growth, and a treatment clock that modulates the response to reperfusion and to adjunctive or neuroprotective therapy. Human cohorts have reported larger ischaemic cores and faster infarct growth after night-time onset or during night-time interhospital transfer, the latter measured directly with serial diffusion-weighted imaging, and time-of-day differences in thrombectomy outcome, but these associations are vulnerable to confounding by uncertain onset times, out-of-hours care and the gap between clock time and internal circadian phase. In rodents, three neuroprotective strategies reduced infarction when given during the animals’ inactive phase but not during the active phase, a mismatch that may have contributed to failed translation; other experiments disagree about which phase is more damaging. Large pragmatic trials of bedtime antihypertensive dosing have been neutral. We propose a ten-item CHRONO-STROKE minimum reporting dataset, which is author-proposed and unvalidated and intended to supplement existing consensus data elements, a clock-time-stratified design for trials of adjunctive therapy, and five testable predictions, as a means of establishing whether circadian biology deserves a place in acute stroke decision-making.

Authors

Institutions

Publication Details

Journal
BioMed
Published
2026-11-16
DOI
https://doi.org/10.3390/biomed6040024
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ischaemic Stroke Keeps Time: A Critical Review of Circadian Biology from Thrombus Formation to Translational Failure

Vikram Khardenavis, Anirudda Deshpande
3 links
BioMed
Acute Ischemic Stroke Management
article

Ischaemic Stroke Keeps Time: A Critical Review of Circadian Biology from Thrombus Formation to Translational Failure

Vikram Khardenavis, Anirudda Deshpande
article en

Abstract

Ischaemic stroke does not occur at random hours. Onset clusters in the morning, and several physiological correlates of that pattern are well described: an endogenous circadian peak in circulating plasminogen activator inhibitor-1, platelets that aggregate more readily in the hours after rising, and the morning surge in blood pressure. What remains unsettled is whether the hour of onset also influences how quickly brain tissue is lost and how well it responds to treatment. This critical narrative review draws together molecular, experimental and clinical evidence and organises it as a Three-Clock Model: a trigger clock that sets when vessels occlude, a tissue clock that governs the pace of infarct growth, and a treatment clock that modulates the response to reperfusion and to adjunctive or neuroprotective therapy. Human cohorts have reported larger ischaemic cores and faster infarct growth after night-time onset or during night-time interhospital transfer, the latter measured directly with serial diffusion-weighted imaging, and time-of-day differences in thrombectomy outcome, but these associations are vulnerable to confounding by uncertain onset times, out-of-hours care and the gap between clock time and internal circadian phase. In rodents, three neuroprotective strategies reduced infarction when given during the animals’ inactive phase but not during the active phase, a mismatch that may have contributed to failed translation; other experiments disagree about which phase is more damaging. Large pragmatic trials of bedtime antihypertensive dosing have been neutral. We propose a ten-item CHRONO-STROKE minimum reporting dataset, which is author-proposed and unvalidated and intended to supplement existing consensus data elements, a clock-time-stratified design for trials of adjunctive therapy, and five testable predictions, as a means of establishing whether circadian biology deserves a place in acute stroke decision-making.

BioMedVol. 6(4)
Altnagelvin Area Hospital (GB), Western Health and Social Care Trust (GB), Kokilaben Dhirubhai Ambani Hospital (IN)
Good health and well-being
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon